Kraneshares Tr Msci All China Health Care Index Etf Newsroom

Summit Therapeutics Shares Are Trading Lower. The Company's Partner Akeso Received FDA Approval for Its PD-1 Monoclonal Antibody, Penpulimab-kcqx, in Combination With Cisplatin or Carboplatin and Gemcitabine. The FDA Also Approved Penpulimab-kcqx as a...

BenzingaApr 25 15:19 ET

'Akeso Wins Chinese Approval For Cancer Drug Positioned To Rival Merck's Keytruda; Company Discloses Early Data Hinting At A Survival Benefit' - STAT News

BenzingaApr 25 11:51 ET

Summit Extends Gains as Cancer Drug Outperforms BeiGene's Tevimbra

Seeking AlphaApr 24 14:22 ET

Jiangsu Hengrui Pharmaceuticals: Authorized revenue becomes the "accelerator" for performance.

Personnel, products, and research and development are gradually becoming Global.

wallstreetcnApr 24 07:29 ET

The upfront payment for the new ADC drug has boosted revenue, Jiangsu Hengrui Pharmaceuticals' Q1 revenue increased by 20.14% year-on-year, and net income increased by 36.9% | Earnings Reports insights.

In Q1, Jiangsu Hengrui Pharmaceuticals' revenue increased by 20.14% year-on-year, net income attributable to the parent company increased by 36.9%, and net income after deductions increased by 29.35% year-on-year. The significant increase in net income was primarily due to the company receiving a $75 million upfront payment for external licensing.

wallstreetcnApr 24 06:03 ET

Summit Therapeutics' Partner Akeso HARMONi-6/AK112-306 Phase 3 Trial Of Ivonescimab In Combination With Platinum-based Chemotherapy Compared With Tislelizumab Met Its Primary Endpoint Of Progression-Free Survival For Locally Advanced Or Metastatic...

BenzingaApr 23 06:18 ET

Asia Markets Mixed Amid Lingering Trade Tensions; U.S. Futures Rose After Wall Street's Sharp Sell-off

Seeking AlphaApr 22 01:18 ET

Asia-Pacific Markets Set to Open Lower After Trump's Attack on Fed Chair Sends Wall Street Tumbling

CNBCApr 21 20:02 ET

JP Morgan Maintains Overweight on BeiGene, Raises Price Target to $317

BenzingaApr 21 12:04 ET · Ratings

People's Bank of China Keeps LPR Rate Steady for 6th Month

Seeking AlphaApr 21 00:37 ET

Asia Markets Rise as Trade Talks Eyed; Investors Assess Economic Data in the Region

Seeking AlphaApr 17 01:38 ET

Has the SSE Health Care theme Index risen again? This year, the public fund performance has shuffled, with the highest return of the health care theme Fund exceeding 44%, and Inflow of capital has accelerated.

As of April 16, two SSE Health Care theme Index Funds have entered the top 10 performances of actively managed equity funds this year; Since April, multiple Hwabao WP CSI Medical Service ETFs have seen significant net subscriptions, with the total amount of fund shares for these medical ETFs reaching a new high; Fund managers believe that the pharmaceutical sector is not just undervalued in parts, but is comprehensively undervalued, and the nature of Innovative Drugs has changed.

cls.cnApr 16 20:31 ET

China's March Retail Sales Rise 5.9%; Industrial Output Rises 7.7%; Unemployment Rate Falls 5.2%

Seeking AlphaApr 15 22:07 ET

Brokerage morning meeting highlights: The current rare earth Sector is well-prepared for both offense and defense, it is recommended to pay active attention.

In today's Brokerage morning meeting, China Securities Co.,Ltd. proposed that the current Rare Earth Sector has both offensive and defensive capabilities, suggesting active attention; HTSC indicated that the AI Medical industry trend is accelerating; China International Capital Corporation believes that the total telecom capital expenditure will be under pressure in 2025, focusing on structural growth opportunities such as computing power and 5G-A.

cls.cnApr 15 20:19 ET

Brokerage morning meeting highlights: The short-term bottom of the A-shares has already formed, looking for structural opportunities amid fluctuations.

At today's Brokerage morning meeting, Everbright believes that the market may mainly feature structural trends and hot sector rotations; Sinolink stated that they remain Bullish on the growth potential of Innovative Drugs companies in the Hong Kong and A shares markets; Galaxy Securities indicated that a short-term bottom in A shares has already formed and is seeking structural opportunities amidst the fluctuations.

cls.cnApr 14 20:14 ET

Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.

① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.

cls.cnApr 14 20:14 ET

China's March Trade Surplus Above Estimates, Exports Surge While Imports Fall

Seeking AlphaApr 13 23:47 ET

This week adds 14 more! WUXI APPTEC and several other stocks disclosed repurchases and increased loan quotas exceeding 0.2 billion yuan, a list of related A-shares overview.

According to incomplete Statistics from the Financial Association, as of the time of this report, over 14 companies announced that associated parties had procured shareholding repurchase loans exceeding 0.2 billion yuan; HAIER SMARTHOME and Rongsheng Petro Chemical received the highest specialized loan quotas for repurchase shareholding, both at 1.8 billion yuan.

cls.cnApr 13 05:10 ET

AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

China's March Inflation Drops for Second Straight Month; Issues Warning on Travel to U.S.

Seeking AlphaApr 10 01:29 ET